Equity Overview
Price & Market Data
Price: $1.28
Daily Change: +$0.05 / 3.91%
Daily Range: $1.27 - $1.30
Market Cap: $46,687,008
Daily Volume: 8,643
Performance Metrics
1 Week: -7.52%
1 Month: -21.66%
3 Months: -14.58%
6 Months: -39.11%
1 Year: -13.99%
YTD: -12.14%
Company Details
Employees: 5
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.